Borgström F, Johnell O, Kanis J A, Jönsson B, Rehnberg C
Medical Management Centre, Karolinska Institutet, Stockholm, Sweden.
Osteoporos Int. 2006 Oct;17(10):1459-71. doi: 10.1007/s00198-006-0107-0. Epub 2006 Jul 18.
Intervention thresholds (ITs), the 10-year hip fracture risk at which treatment can be considered to be cost-effective, have previously been estimated for Sweden and the UK.
The aim of this study was to provide a Markov cohort model platform for a multinational estimation of thresholds at which intervention becomes cost-effective and to investigate and determine the main factors behind differences in these thresholds between countries.
Intervention thresholds were estimated for Australia, Germany, Japan, Sweden, Spain, the UK and USA using a societal perspective. The model was populated with as much relevant country-specific data as possible. Intervention was assumed to be given for 5 years and to decrease the risk of all osteoporotic fractures by 35%. The societal willingness to pay (WTP) for a quality-adjusted life-year (QALY) gained was set to the gross domestic product (GDP) per capita multiplied by two. In the base case analysis, the 10-year hip fracture probability at which intervention became cost-effective varied across ages and countries. For women starting therapy at an age of 70 years, the IT varied from a hip fracture probability of 5.6% in Japan to 14.7% in Spain. The main factors explaining differences in the IT between countries were the WTP for a QALY gained, fracture-related costs and intervention costs.
The ITs presented in this paper are appropriate for use in treatment guidelines that consider health economic aspects, and they can be used in combination with fracture risk prediction algorithms to improve the selection of patients who are suitable for osteoporotic intervention.
干预阈值(ITs),即治疗被认为具有成本效益时的10年髋部骨折风险,此前已针对瑞典和英国进行了估算。
本研究的目的是提供一个马尔可夫队列模型平台,用于跨国估算干预变得具有成本效益的阈值,并调查和确定各国这些阈值差异背后的主要因素。
从社会角度估算了澳大利亚、德国、日本、瑞典、西班牙、英国和美国的干预阈值。该模型尽可能多地纳入了各国相关的特定数据。假设干预为期5年,并将所有骨质疏松性骨折的风险降低35%。获得一个质量调整生命年(QALY)的社会支付意愿(WTP)设定为人均国内生产总值(GDP)乘以2。在基础案例分析中,干预变得具有成本效益的10年髋部骨折概率因年龄和国家而异。对于70岁开始治疗的女性,干预阈值从日本的髋部骨折概率5.6%到西班牙的14.7%不等。解释各国干预阈值差异的主要因素是获得一个QALY的WTP、骨折相关成本和干预成本。
本文提出的干预阈值适用于考虑卫生经济方面的治疗指南,并且可以与骨折风险预测算法结合使用,以改善适合骨质疏松干预患者的选择。